Pandemic trials: evidence-based medicine on steroids

James D. Chalmers

Source: Eur Respir J, 56 (6) 2004116; 10.1183/13993003.04116-2020
Journal Issue: December

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
James D. Chalmers. Pandemic trials: evidence-based medicine on steroids. Eur Respir J, 56 (6) 2004116; 10.1183/13993003.04116-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
What is evidence-based medicine?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006

Excellency of anti-tuberculosis primary care: an evidence-based medicine challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 142s
Year: 2005

Pandemic influenza: using evidence on vaccines and antivirals for clinical decisions and policy making
Source: Eur Respir J 2006; 27: 661-663
Year: 2006

Clinical trials during the COVID-19 pandemic: research design and lessons
Source: Eur Respir Monogr 2021; 94: 214-231
Year: 2021

The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group
Source: Eur Respir J, 54 (3) 1901511; 10.1183/13993003.01511-2019
Year: 2019

Update of the European paediatric respiratory medicine syllabus
Source: Breathe, 15 (3) 173; 10.1183/20734735.0188-2019
Year: 2019

Advocacy in respiratory medicine: European medicines agency
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011

Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021

Triple therapy trials in COPD: a precision medicine opportunity
Source: Eur Respir J, 52 (6) 1801848; 10.1183/13993003.01848-2018
Year: 2018

Research in respiratory medicine: Clinical trials
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011

Transparency in evidence-based pediatric asthma guidelines: GRADE and the other considerations
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011

Consensus-based recommendations in respiratory medicine
Source: Eur Respir J, 56 (6) 2002889; 10.1183/13993003.02889-2020
Year: 2020

Facing a new era: how does the pandemic change sleep medicine and practice?
Source: Sleep and Breathing Conference 2021
Year: 2021

Translational medicine lessons from H1N1
Source: International Congress 2015 – Pandemics and emerging infections
Year: 2015

Noninvasive strategies in COVID-19: epistemology, randomised trials, guidelines, physiology
Source: Eur Respir J, 57 (2) 2004247; 10.1183/13993003.04247-2020
Year: 2021

Guideline adherence in the management of pandemic flu: From panic to pragmatic
Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities
Year: 2010

Fundamentals of risk communication: How to talk to patients and the public about Pandemic H1N1
Source: Annual Congress 2009 - Meet the Risk Communication Experts: "Fundamentals of risk communication: How to talk to patients and the public about pandemic H1N1"
Year: 2009

Respiratory medicines for children: current evidence, unlicensed use and research priorities
Source: Eur Respir J 2010; 35: 247-265
Year: 2010

Adaptive servoventilation in clinical practice: beyond SERVE-HF?
Source: ERJ Open Res, 3 (4) 00078-2017; 10.1183/23120541.00078-2017
Year: 2017